Benefit verification (BV) provides a detailed understanding of out of pocket costs for the prescribed treatment. Amy Jones details how AI is aiding the BV process.
Amy Jones
Advertisement
Amy Jones is Director, Product Strategy e-Technologies, Lash Group, a part of AmerisourceBergen.
Articles by Amy Jones
Advertisement
Latest Updated Articles
- AI and Benefit Verification: Providing Faster Access to Medicines
Published: August 28th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
5
